Monday, November 30, 2020
Home Tags Congress

Tag: Congress

SIU Virtual Congress 2020: Is Lymphadenectomy Necessary in Prostate Cancer?

(UroToday.com) The Société Internationale d'Urologie (SIU) 2020 Virtual Annual Congress featured a session on the utility of lymphadenectomy in urologic cancer, including a discussion of...

SIU Virtual Congress 2020: Debate: Management of the Metastases in Oligometastatic...

(UroToday.com) At the Société Internationale d'Urologie (SIU) 2020 Virtual Annual Congress’ debate on the management of oligometastatic prostate cancer, Dr. Patrick Cheung argued that metastases...

Dow Edges Higher as Fed’s Powell Seeks Support From Congress

Stocks traded mixed Tuesday after Federal Reserve Chairman Jerome Powell said the U.S. recovery would be weak without additional fiscal support from...

ESMO Virtual Congress 2020: Treatment in CARD Eligible Metastatic Castration Resistant...

(UroToday.com) The CARD trial was a randomized open-label study of cabazitaxel versus the alternative anti-androgen therapy in patients with metastatic castration resistant prostate cancer (mCRPC)...

NuCana Presents Three Posters at the ESMO Virtual Congress 2020 Nasdaq:NCNA

Encouraging Efficacy Signals Observed in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer in the Phase Ib Study of NUC-3373 (NuTide:302) NUC-3373’s...

Sumitomo Dainippon Pharma Oncology Presents Findings from Phase 1 Clinical Study...

Sumitomo Dainippon Pharma Oncology Presents Findings from Phase 1 Clinical Study Evaluating Investigational Agent Dubermatinib in Patients with Advanced Solid Tumors at ESMO 2020...

ESMO Virtual Congress 2020: Pembrolizumab plus Enzalutamide in Patients with Abiraterone...

(UroToday.com) The PD-1 inhibitor pembrolizumab has shown antitumor activity in patients with heavily pre-treated, PD-L1-positive advanced prostate cancer and in PD-L1-positive and PD-L1-negative patients...

Veru Announces ESMO Congress 2020 Oral Presentation of Positive Clinical Results...

—Advancing VERU-111 to a Pivotal Phase 3 Clinical Program— MIAMI, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an...

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386...

  HOUSTON and VANCOUVER, BC, Sept. 17, 2020 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel...
20,764FansLike
2,460FollowersFollow
16,600SubscribersSubscribe

EDITOR PICKS